Unknown

Dataset Information

0

Association of Lymphovascular Space Invasion With Locoregional Failure and Survival in Patients With Node-Negative Oral Tongue Cancers.


ABSTRACT: Importance:The indications for adjuvant therapy in resected oral tongue cancers are based on both clinical and pathological factors, with clear evidence for adjuvant radiation in patients with pathologically positive neck lymph nodes, positive margins, and extracapsular extension, but the data for patients with no nodal disease are sparse. Objective:To investigate determinants of failure and survival in patients with node-negative oral tongue cancer. Design, Setting, and Participants:Medical records for patients with oral tongue cancer treated with definitive surgery from 2003 to 2013 were reviewed. All patients were cN0 negative and classified as pathologically node-negative (pN0) if a neck dissection was performed. Patients received adjuvant radiotherapy (RT) or chemoradiotherapy (CRT) based on standard clinical and pathological determinants. Main Outcomes and Measures:Kaplan-Meier and multivariable (MVA) logistic regression and Cox proportional hazard regression analyses were performed to identify patient, tumor, and treatment characteristics predictive of locoregional control (LRC) and overall survival (OS). Results:A total of 180 patients met entry criteria, with a median follow-up time of 4.9 years (range, 0.9-12.5 years); 102 patients (56.7%) were female and 42 patients (23.3%) were younger than 45 years at diagnosis. One hundred fifty-three patients (85%) had T1/T2 tumors, and 112 patients (62%) had elective neck dissections with confirmed pN0. Lymphovascular space invasion (LVSI) was present in 36 patients (20%). On MVA, LVSI (OR, 0.06; 95% CI, 0.02-0.19; P?

SUBMITTER: Cassidy RJ 

PROVIDER: S-EPMC5398912 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Association of Lymphovascular Space Invasion With Locoregional Failure and Survival in Patients With Node-Negative Oral Tongue Cancers.

Cassidy Richard J RJ   Switchenko Jeffrey M JM   Jegadeesh Naresh N   Sayan Mutlay M   Ferris Matthew J MJ   Eaton Bree R BR   Higgins Kristin A KA   Wadsworth Jeffrey T JT   Magliocca Kelly R KR   Saba Nabil F NF   Beitler Jonathan J JJ  

JAMA otolaryngology-- head & neck surgery 20170401 4


<h4>Importance</h4>The indications for adjuvant therapy in resected oral tongue cancers are based on both clinical and pathological factors, with clear evidence for adjuvant radiation in patients with pathologically positive neck lymph nodes, positive margins, and extracapsular extension, but the data for patients with no nodal disease are sparse.<h4>Objective</h4>To investigate determinants of failure and survival in patients with node-negative oral tongue cancer.<h4>Design, setting, and partic  ...[more]

Similar Datasets

| S-EPMC5605436 | biostudies-literature
| S-EPMC6858972 | biostudies-literature
| S-EPMC3544453 | biostudies-literature
| S-EPMC7526048 | biostudies-literature
| S-EPMC6852322 | biostudies-literature
| S-EPMC8241765 | biostudies-literature
| S-EPMC11246470 | biostudies-literature
| S-EPMC10778553 | biostudies-literature
| S-EPMC7523233 | biostudies-literature
| S-EPMC4524781 | biostudies-literature